Adicet Bio, Inc.
ACET
$0.8345
$0.00660.80%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | 13.59% | 16.08% | 17.90% | 17.59% | -19.22% |
Total Depreciation and Amortization | -0.56% | 0.03% | 6.07% | 19.50% | 43.76% |
Total Amortization of Deferred Charges | -63.41% | -71.15% | 30.00% | -61.17% | -59.80% |
Total Other Non-Cash Items | -63.76% | -53.94% | -44.17% | -37.37% | 115.59% |
Change in Net Operating Assets | 54.95% | -45.39% | -2,292.46% | -202.05% | -176.31% |
Cash from Operations | -7.85% | -2.65% | 1.43% | -3.03% | -9.42% |
Capital Expenditure | -33.67% | 14.96% | 74.96% | 90.04% | 89.25% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -- | -- | -- | -- | -- |
Cash from Investing | -5,497.54% | -4,271.02% | -2,571.19% | 90.04% | 89.25% |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | -13.35% | -13.43% | 53,689.64% | 8,441.61% | 148.50% |
Repurchase of Common Stock | -34,164.77% | -34,164.77% | -64,114.00% | -11,349.17% | 86.86% |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | -99.73% | -99.79% | 47,063.98% | 3,146.98% | 160.40% |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -1,101.91% | -1,457.78% | -2.42% | 21.77% | 133.72% |